Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

USD 1,500

* Required Fields

USD 1,500


Be the first to review this product

The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hospitals are the primary users of apheresis equipment and solutions; other users include blood banks and dialysis centers. End users include therapeutic apheresis nurses, referring physicians, hematologists, oncologists, rheumatologists, neurologists, nephrologists, cardiologists, and lipidologists.

The study covers standard plasmapheresis or plasma exchange, extracorporeal immunoadsorption, plateletpheresis, red cell exchange, leukapheresis, and lipidpheresis. The two broad product categories are devices and disposables.

The study discusses key trends that are expected to impact the market, including more applications across different therapeutics segments and diversification aimed at long-term growth. The industry is also witnessing a shift as the adoption of apheresis procedures, with more growth possibilities in autoimmune, renal and rare disease therapeutic areas.

The study examines the 2016 market size and presents a forecast through 2021, as well as the current market share of therapeutic areas. It offers a regulatory overview and a look at reimbursement and pricing trends. It also discusses the competitive landscape and the key market players in the industry. Tier I companies include Fresenius Medical Care Holdings, Terumo BCT, Haemonetics Corporation, Asahi Kasei Medical Company, Cerus Corporation, and B. Braun Melsungen AG. Tier II companies include Kaneka Corporation and Nikkiso Co., Ltd.

Key questions the study will answer include:
• What are the market drivers and restraints?
• What is the current market size?
• What is its potential for growth?
• What are the key trends regarding reimbursements and pricing, and how are they expected to affect market growth?
• Who are the key market participants, and what is the current competitive structure?
• What are the key market growth opportunities, and how will they affect stakeholders?

Table of Contents

Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021Executive SummaryKey FindingsMarket OverviewMarket DefinitionMarket Scope and SegmentationMarket Scope and Segmentation (continued)Key Questions This Study Will AnswerValue Chain AnalysisMarket TrendsMarket DynamicsMarket Dynamics (continued)Market Impact of Top TrendsRegulatory OverviewReimbursement TrendsDrivers and RestraintsMarket DriversMarket RestraintsForecast and TrendsForecast AssumptionsMarket Forecast ScenariosForecast by Therapeutic CategoryPricing TrendsCompetitive LandscapeCompetitive EnvironmentKey Vendors to WatchKey Service Providers to WatchGrowth Opportunities and Companies to ActionGrowth Opportunity 1—Growing Application and Scope of Therapeutic PlasmapheresisGrowth Opportunity 2—Increasing Focus on Diversifying Product ApplicationsGrowth Opportunity 3—Pathogen-Reduced Platelets and PlasmaStrategic ImperativesECP Treatments—Market Insights ECP Treatments—Market InsightsECP Treatments—Market Insights (continued)AppendixDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

therapeutic apheresis
therapeutic plasmapheresis
therapeutic apheresis

Related Research

Release Date : 29-Dec-17

Region : North America

Release Date : 20-Dec-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.